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Abstract We prospectively considered 65 patients admitted for a spontaneous pneumothorax (SP) to describe the
pragmatic management of SP, the ¢rst recurrence-free interval aftermedical therapeutic procedure and to specify the
¢rst recurrence risk factors over a 7-year period inthese patients treatedmedically.
The treatment options were observation alone (9%), needle aspiration (6%), small calibre chest tube (Pleuro-
catheter1) drainage (28%) or thoracic tubedrainage (49%), andpleurodesiswithvideo-assistedthoracic surgeryprocedure
(8%).Duration of the drainage and length of hospital stay were shorter in the Pleurocatheter1group than in the thoracic
tube group (P5 0?01). Among the 47 patients (72%) with a ¢rst SP and treatedmedically, nine patients (19%) had a ¢rst
homolateral recurrence (FHR) during a mean follow-up of 84+13 months.Recurrence-free intervals ranged from1to 24
months (mean+SD: 9?3+8?4months).FHR casesweremore frequent inthe Pleurocatheter1group (P5 0?04).
Analysis of potential risk factors showed thatthe patient’s height and a previous homolateral SP episode are indepen-
dentrecurrence risk factors.c 2001Harcourt Publishers Ltd
doi:10.1053/rmed.2000.1028, available online athttp://www.idealibrary.comon
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Spontaneous pneumothorax (SP) is de¢ned as the pre-
sence of air in the pleural cavity, irrespective of any trau-
matic or iatrogenic context. It is said to be idiopathic or
primary in the absence of anydisease detectable through
a clinical and/or radiological examination. Inmostcases it
is a benign disease although itmaybecomeworrying due
to frequent, unpredictable recurrences ö30^35%
according to the series andmethodof treatment (1). Pro-
cedures for the initial treatment of SP may varyöobser-
vation, needle aspiration, small or large calibre chest
tube drainage, or pleurodesis with video-assisted thor-
acic surgery procedure.The choice of method is contro-
versial, depending on criteria associated with the
pneumothorax such as degree of detachment and pre-
sence or absence of symptoms, and on the practitioner’s
experience of each technique. In fact, other factors such
as recurrence risk might also de¢ne the initial therapy
(2). In 1993, guidelines for SP management were pub-
lished. They proposed a therapeutic strategy based onReceived10 February 2000 and accepted in revised form 23 July 2000
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respiratory disease and the degree of SP (3). Several pre-
vious surveys have shown a recurrence risk of SP,
principally in connection with the presence of an under-
lying respiratory disease (2,4,5). However, few studies
have dealt with the speci¢c risk of recurrence (6).
Initiated before the guidelines were published, our
survey aims to describe the pragmatic management of
SP in a French Department of Respiratory Disease, the
¢rst recurrence-free interval after medical therapeutic
procedure and to specify the ¢rst recurrence risk
factors over a 7-year period in this patients treated
medically.
MATERIALANDMETHODS
In ourRespiratoryDiseaseDepartment,we screened 78
consecutive patients hospitalized for the ¢rst time for a
SP between 1 January 1988 and 31 September l991. They
ranged from17 to 88 years of age. Among the 78patients
considered, 13 were lost to follow-up despite general
practitioner (GP) contact and patient phone number re-
search.Therefore, the ¢les of 65 patients were analysed.
For each patient, data included: height, weight and body
surface; family or personal history of the SP; side of SP;
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tial SP (detachment of the apical lung surface inferior to
3 cm in the mid-clavicular line) or complete SP (detach-
ment of the apical lung surface superior to 3 cm in the
mid-clavicular line); revealing symptoms; interval before
treatment started; therapeutic procedure used; date of
recurrence.
The therapeutic protocolwas pragmatically chosenby
the chest physician primarily responsible for the patient:
observation alone; needle aspiration; small chest tube
drainage 8 F, length: 50 cm (Pleurocatheter1, Labora-
toire Plastimed, Saint-Leu-La-Fore“ t, France); thoracic
tube drainage (PVC) Ch.14 to Ch. 24, length: 30 cm (La-
boratoireVygon, Ecouen, France); surgical pleurodesis.
Once the drainagewas chosen, the chest tubewas in-
serted after local anaesthesia and intercostalmuscle dis-
section either in a frontal position (second intercostal
space in the midclavicular line) with the patient in dorsal
decubitus, or in an axillary position (¢fth or sixth inter-
costal space in the mid-axillary line) if the patient could
withstand being in lateral decubitus on the side opposed
to the SP.Then, the chest tube was attached to a Heim-
lich £utter valve and connected to thevacuum sourcevia
a two-bottle regulated system adjusted to create a de-
pression of 20^50 cm H2O. After 24 h without bubbling
in the water seal bottle and a complete radiological re-
expansion of the lung, continuous aspiration was
stopped. The chest tube was left in place for 24h with
the Heimlich valve at atmospheric pressure. Finally, if a
clinical and radiographical examination failed to reveal a
detachment, the chest tube was removed. The patient
left the department once a ¢nal radiological control
showed no detachment. The treatment was considered
a failure when the bubbling continued after 10 days of
drainage (lengthy air leak).Themedical therapeutic pro-
cedure (i.e. observation, needle aspiration, small chest
tube drainage, thoracic tube drainage) adopted for the
survey was that allowing the resolution of the SPöcon-
sidered as a successöduring the initial hospitalization.
Once a surgical pleurodesis was chosen, transfer to
the Thoracic Surgery Department was decided by the
chest physician primarily responsible for the patient in
case of a personal controlateral SP history, a personal
previous recurrence (i.e. two previous SP episodes), or
by one of the authors ( J.M.V., P.C., P.V., A.T.) after failure
of the drainage (more than10 days with bubbling).When
surgical pleurodesis was performed, the patient was ex-
cluded from the survey. One month after the SP in the
group of patients successfully treated with a medical
procedure, we assessed blood a1anti-trypsin, a chest X-
ray, spirometry withwhole body plethysmography (Jae-
ger MasterLab-IsoFlow,Wuerzburg,Germany) and a dif-
fusing capacity test (DLCO) and a computed tomography
(CT) scan of lung to calculate theWarner bleb score (7).
The Warner bleb score was evaluated independently
from data collection by two physicians, a radiologist(F.L.) and a chestphyscian (M.T.L.)whohadnot takenpart
in any other way.
Recurrence was de¢ned by the homolateral recur-
rence of the SP. The rate of ¢rst recurrence was calcu-
lated by observing the patients included in the survey at
the time of the ¢rst SP episode treatedmedically.The in-
vestigation regarding the recurrence was conducted in
March 1997, average delay 84+13 months. To take into
account a recurrence occurring or treated in another
hospital, information was collected by a simple postal
questionnaire from the GP or by phone when the ques-
tionnaire was not returned. The patient was directly
contactedwhen the GP had lost contact.
The statistical analysis was carried out in several
stages: (a) descriptive univariate analysis, the means
being given with their standard deviation (mean+SD);
the chi-squared test to analyse contingency tables; the
student’s t-test to compare the quantitative variables. A
di¡erence was considered as statistically signi¢cant
when P5 0?05? (b) Bivariate analysis using recurrence
as a dependent variable, the other variables being clini-
cally signi¢cant as independent variables according to
the literature; and (c) analysis through logistic step-by-
step regression according to the Hosner and Lemeshow
method, with a conservative threshold at P5 0?25.
RESULTS
Population
Among the 65 subjects analysed, therewere 49men and
16 women aged 30+12 years on average at the time of
the initial SP. The average body surface was
1?173+0?12m2 for men and l?58+0.13m2 for women
(t=4?2,P50?0001).Five patients (8%) had a previous SP
history among their sisters and brothers and 2l patients
(32%) had a personal SP history,18 of them on the same
side. Fifty-two patients (80%) were smokers.Thirty-two
SPs were on the right side, 33 on the left. Forty-six pa-
tients (71%) had a complete SP and19 patients (29%) had
a partial SP.
Pain was the most usual revealing symptom (85%); it
was always sudden and appeared without any triggering
factor. Dyspnoea was also present in 25% of the cases
and cough in 3%. In the group of patients treated with
drainage, the interval between the ¢rst symptoms and
the time of drainagewas 45+54h.
Table 1 shows the distribution of therapeutic proto-
cols.Two-thirds of the patients were treatedwith a drai-
nage (thoracic tube drainage or Pleurocatheter1).There
was no signi¢cant di¡erence in the patients’ age or in the
size of the detachment whatever therapeutic protocol
was proposed (data not shown).
Ten lengthy bubblings were observed, three of which
required surgical pleurodesis. Drainage complications
appeared in six of the 60 non-surgical patients (10%):
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(one with thoracic tube drainage and one with Pleuro-
catheter1) without any speci¢c treatment and onewith
Pleurocatheter1 considered as serious because of re-
quiring a surgical haemostasis, one clotted Pleurocath-
eter1, one skin infection around the incision of a
thoracic tube drainage and one thoracic tube drainage
excluded.
Table 2 shows the duration of drainage according to
the size of detachment and the type of drainage used.
Duration of the drainage and the length of hospital stay
were shorter in the Pleurocatheter1 group than in the
thoracic tube group (P5 0?01); on the other hand, the
length of hospitalization following themoment the drain
was removedwas shorter when a Pleurocatheter1 was
used comparedwith thoracic tube drainage, but not sig-
ni¢cantly (1?7+1?3 daysvs. 2?6+3 days, t=1?4,P=0?18).
Fifty-three patients (81%) had a CTscan1month after
the SP episode. Itwas normal in 20 of them. As therewas
no systematicmillimetric section, theWarner bleb score
could only be calculated for 25 CTscans (47%).The score
was zero in all the patients with a partial SP (n=5); the
mean value of theWarner bleb score in the group of pa-
tients with a complete SP (n=20) was 22?8+28?6 on
both sides and 17?1+19?8 when considering the SP side
alone.
Forty-¢ve patients (67%) performed a spirometry 1
month after the SP episode.Themeanvalues of themain
parameters [forced expiratory volume in 1sec, (FEV1),
vital capacity (VC), residual volume (RV)] were normal
(99+19%,100+17%, and109+33%, respectively). Seven-
teen patients (26%) had a DLCO test.Themean valuewas
normal (81+22%).TABLE 1. Therapeutic protocols used




Thoracic tube drainage 32(49)
Surgicalpleurodesis 5(8)
TABLE 2. Duration of drainage and length of hospital stay
Complete SP Partial SP P
Duration drainage (days) 5?5+2 6?5+3 N
Length of stay (days) 7?7+3?9 7?5+4.1 N
P: comparison between complete SP andpartial SP.
P’: comparisonbetweenthoracic tube drainage group and PleurRecurrence survey
Among the 65 patients in our survey, 47 were included at
the time of the ¢rst SP episode and had no surgical man-
agement. Among these 47, ninehad a ¢rsthomolateral re-
currence (FHR) during the follow-up period, i.e. a 19%
FHR rate. This group of patients consisted of eight men
and one woman, aged 27?4+7?3 years. Their average
body surface was 1?67+0?1m2 and that of the group of
patients who had su¡ered no recurrence was
1?69+0?15m2 (NS). Seven patients (78%) had a complete
SP.Therewasno di¡erencebetween the smokinghabits of
the patients who had FHR and those with no recurrence
(12?2+9?8 vs. 8+7?3 pack-years, respectively).Two non-
smokers were in the group with FHR and four in the re-
currence-free group (NS). The recurrence-free intervals
ranged from1to 24months (mean: 9?3+8?4months).
The treatment procedures for the initial episode of SP
in thenine above-mentionedpatients and therecurrence
rate are shown inTable 3. The number of patients with
FHR was signi¢cantly higher in the Pleurocatheter1
group (P50?04). Fifty per cent of the Pleurocatheter1
drainage complications treated irrespective if lengthy air
leak occurred in patients who had a ¢rst recurrence.
However, the mean drainage duration and the mean
length of hospital stay showed no signi¢cant di¡erence
between the patients with FHR and the recurrence-free
patients: 4?7+2?3 vs. 5?6+2?4 days and 6?8+2?8 vs.
7?8+3?7 days, respectively.There was no statistical dif-
ference either in serum a1 anti-trypsin (2?6+0?5 vs.
2?7+0?5mgml71), Warner bleb score on the CT scan
whether calculated on both sides (8?6+1?4 vs.
23?3+30?6) or on the SP side (3?7+5?3 vs. 12?6+19?7).
Two of the patients (3%) presented a contralateral SP
episode during the follow-up period.
Analysis ofmissing data
The limited number of cases available for the Warner
bleb score (n=25) made it impossible to keep this vari-
able in the rest of the statistical survey.The variable ‘size
of the detachment’ was not considered either as its de-
gree of signi¢cance was below the conservative thresh-
old assigned (odds ratio=0?91, 95% con¢dence interval
0?26^2?15,P= 0?86).Thoracic tube drainage Pleuro catheter1 P’
S 6?3+2?4 4?6+2 0?01
S 8?8+3?7 6?2+2?5 0?01
ocatheter1group.
TABLE 3 Recurrence rate according to therapeutic protocolused
Therapeutic protocols Recurrences (n=9) Rate (%)
Observation (n=6) 1 17
Needle aspiration (n=4) 0 0
Pleurocatheter1 (n=18) 6 33*
Thoracic tube drainage (n=32) 2 6
P5 0.04 between Pleurocatheter1group and thoracic tube drainage group.
TABLE 4 Statisticalmodelling
Regression coe⁄cient P Oddsratio
Intercept 0?9 0?21
Sex 70?52 0?41 0?59
Height 0?99 0?23 1?001
Personalhomolateralpast historyof SP 0?99 0?14 2?7
DLCO value 0?16 0?81 1?002
SP: spontaneouspneumothorax.
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regression
The initial logistic regression model included nine vari-
ables: sex, age, weight, height, smoking habits, personal
history of pneumothorax, time between ¢rst symptoms
and drainage, type of drainage and DLCO value.The una-
voidable variables chosen according to the literature
were sex, height and DLCO value. Some variables were
turned into dichotomic variables to allow modelling
(sex, smoking habits, personal SP history). Age, height,
weight, time between the ¢rst symptoms and drainage,
andDLCO valuewerekept as quantitativevalues; the type
of drainage was left as a four-grade qualitative variable.
Interactions were not tested as none seemed clinically
relevant. The ¢nal modelling of the logistic regression
(Table 4) showed that sex was not a risk factor for SP
recurrence, unlike height and a previous homolateral his-
tory. After adjustment on the other factors, DLCO value
was not a recurrence risk factor, unlike in bivariate ana-
lysis where it was on average lower in the group of pa-
tients with FHR than in the FHR-free group: 72% vs.
86%,P=0?2, respectively.
DISCUSSION
This study presents the results of a pragmatic therapeu-
tic management of SPs in a respiratory unit. It shows
that: (a) the rate of long term success is 81%, from 67%
to100% according to the therapeutic protocol adopted;(b) the average length of hospital stay for the patients
treated by Pleurocatheter1 is signi¢cantly shorter than
for those treated by thoracic tube drainage; (c) the re-
currence rate is low, but seems higher in the group trea-
ted by Pleurocatheter1; (d) most of the time,
recurrences occur within the 2 years following the initial
episode despite a long-term follow-up; (e) the Warner
bleb score does not seem useful in the assessment of re-
currence risk; (f) size of detachment is not a predictive
factor for recurrence; (g) heightof patient and aprevious
SP history are risk factors inmultivariate analysis.
The characteristics of our population do not di¡er
from those mentioned in the literature: most SPs occur
in patients under 50 years, and an obviousmalepredomi-
nance is also found (1,2,8). The choice of the treatment
was not randomized in our study, which may bias the
comparative analysis of the e⁄cacy of each procedure,
especially for both drainage systems. However, initial
randomization is not easy on account of the low inci-
dence of this pathology (1,5). In the absence of any guide-
lines (3) at that time to management, it was possible to
guide the therapeutic procedure by using various factors
such as the patient’s dyspnoea level, the extent of SP or
the practitioner’s experience of each technique. How-
ever, SP treatment seems to have been e¡ective since
there was no recurrence in 8 1% of the cases, this rate
being similar to thatmentioned in several other surveys
(2,4,8). The rate of immediate success according to the
therapy was 100% for aspiration and surgery, 94% for
thoracic tube drainage, 83% for observation alone and
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cess rates are 70^90% for thoracic tube drainage (8^10)
and 87^95% for Pleurocatheter1, given that the re-
ported studies do not always concern SPs alone (11^13).
The success rate of observation alone ranges from 24%
(8) to 100% (2), again for pneumothorax with an extent
below15%.Only O’Rourke (8) underlines the potentially
dangerous aspect of this strategy: two deaths in a series
of 168 patients due to compressive pneumothorax oc-
curring in the group of patients with observation alone.
As mentioned in various publications, the needle aspira-
tion rate ranges from 71% to 100%. Combined with a
shorter length of hospital stay and the absence of compli-
cation, such e⁄cacy has inducedmany authors (8^10,14)
to recommend this as ¢rst-line therapy, which is the Brit-
ish Thoracic Society’s opinion (3). On the other hand,
Boutin (15) prefers an interventional attitude from the
very ¢rst episode, i.e. a thoracoscopy allowing a lung
lesional assessment and the treatmentof the causal blebs
(electro-coagulation or endo-GIA forceps resection) fol-
lowedby a pleurodesis with talc powder or pleural abra-
sion to prevent recurrences.He explains this attitude by
the same duration of drainage (4+1days), the absence of
long termcomplications, thatprovided strictrules of talc
volume arerespected (2ml), and the lowrecurrencerate
(below 5%) after this type of pleurodesis. As our study
shows that a previous SP history is an independent factor
for recurrence risk, a pleurodesis could be proposed
when the second episode occurs, and not the third.
There were very few complications of lengthy drainage
apart from lengthy air-leak (9?8%) and these occurred
only with the two drainage systems, being apparently as
frequentwith thoracic tube drainage as with the Pleuro-
catheter1.We choose a shorter persistent air-leakdelay
than others authors; this choice couldprobably underes-
timate the real success of our procedures (16). There
were only two haemorrhagic complications with the
Pleurocatheter1 and only one with thoracic tube drai-
nage. This is contrary to what has been said about the
Pleurocatheter1 and its supposeduntraumatic, less un-
comfortable andpainful nature for thepatient than stan-
dard thoracic tube drainage (11^13). haemorrhagic
complications with the Pleurocatheter1 could be due
to the insertion of the bevelled trocar which is not al-
ways preceded by an intercostal muscle dissection with
forceps, similar to thatmade before setting up a thoracic
tube drainage: introducing the Pleurocatheter1mustbe
done very cautiously after checking the haemostasis and
carefully locating the path level with the top edge of the
lower rib. We have noticed that the average length of
hospital stay for patients treated with the Pleurocath-
eter1 is shorter than those treated by thoracic tube
drainage. The di¡erence seems related with a signi¢-
cantly shorter drainage durationwhen using the Pleuro-
catheter1, a di¡erence Martin has already mentioned
(12). Thus, using a Pleurocatheter1 could be less costly,but only a medical audit would ascertain this by taking
into account, for each type of therapy, the cost of the
equipment, the medical and nursing times necessary for
management, the length of hospital stay and the cost of
the complications and recurrences, even though, accord-
ing to our survey, these are signi¢cantly more frequent
with the Pleurocatheter1.
Our average follow-up time is 7 years, whereas it has
rarely exceeded 6 years in other surveys (2,5,8). In our
work, the global recurrence rate is 19%, i.e. among the
lowest rates in the literature whereas rates between
10^60% have been reported (2,4,5,8^10,12,13). In spite of
this average lengthy follow-up, no ¢rst SP recurrencehas
occurredbeyond the end of the second year (average oc-
currence interval: 9?3.+8?4months).Even if few surveys
have assessed this interval in a homogeneous population
of patients with a ¢rst SP episode, most show identical
¢ndings (5,14).
Patient’s height is a SP recurrence risk factor high-
lighted in our survey. Lippert (4) had already shown the
part played by the height of tall, thin patients in a survey
of 144 subjects, 122 of whom had a SP previous episode.
The pathogenesis of this is unknown.We also studied an
already publishedbleb score (7) butwere unable to high-
light any signi¢cant di¡erence between patients with a
recurrence-free SP and thosewith a ¢rst recurrence. In-
deed, the average bleb score was higher in the recur-
rence-free group than in the ¢rst recurrence group.This
could be due to the restrictive character of our survey
which includes only patients with a previous SP re-
currence, whereas Warner (7) included a high propor-
tion of patients with several SP recurrences treated by
chemical pleurodesis (four patients) or by surgery (four
patients). Resorting to such therapeutic options was
probably induced by pulmonary lesions which were
greater than those in patients with a previous recur-
rence. Some authors have also stressed the importance
of morphologic CT scan of the apical blebs or bullae
when predicting recurrences (17).
In conclusion, studying SP recurrences remains di⁄-
cult because many factors are involved. Choosing the
initial treatment procedure should take into account
the recurrence risks, but no randomized data on a
homogeneous SP population are as yet available to
favour a particular technique. At present, the best way
to optimize SP management is to apply the published
guidelines (3).
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